These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38985632)

  • 1. Prevention of cardiovascular complications in elderly cancer patients.
    Topa E; Rizza M; Iengo M; Cuomo A; Cicia L; Di Sarro E; Miccio M; Ciaccio G; Luise MC; Formisano L; Bianco R; Carlomagno C; Picardi M; Martinelli E; Napolitano S; Troiani T; Ferrara N; Abete P; Tocchetti CG; Mercurio V
    Vascul Pharmacol; 2024 Jun; 155():107354. PubMed ID: 38985632
    [No Abstract]   [Full Text] [Related]  

  • 2. The prevention of cardiovascular disease in cancer survivors.
    Daher IN; Daigle TR; Bhatia N; Durand JB
    Tex Heart Inst J; 2012; 39(2):190-8. PubMed ID: 22740730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin in primary prevention of cardiovascular disease in the elderly.
    Galli M; Andreotti F; D'Amario D; Vergallo R; Montone RA; Porto I; Crea F
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):326-327. PubMed ID: 31504373
    [No Abstract]   [Full Text] [Related]  

  • 4. The Role of Angiotensin-Converting Enzyme Inhibitors and β-Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients.
    Brown SA; Okwuosa TM; Barac A; Volgman AS
    J Am Heart Assoc; 2020 Jan; 9(2):e015327. PubMed ID: 31960742
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: Recommendations From the U.S. Preventive Services Task Force.
    Ann Intern Med; 2016 Jun; 164(12):. PubMed ID: 27064765
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment, behavioral, and psychosocial components of cardiovascular disease risk among survivors of childhood and young adult cancer.
    Berkman AM; Lakoski SG
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25836057
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular side-effects of modern cancer therapy.
    Minami M; Matsumoto S; Horiuchi H
    Circ J; 2010 Sep; 74(9):1779-86. PubMed ID: 20716834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cancer and cardiovascular risk].
    Blanch Gracia P; Mena Sebastià E; Villanueva Vázquez R; Tirapu Sola L; Losa Gaspà F; Freixa-Pamias R; Armario P
    Hipertens Riesgo Vasc; 2021; 38(3):e1-e9. PubMed ID: 33706995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins in the elderly: what evidence of their benefit in prevention?
    Steg PG; Tissot CM
    Arch Cardiovasc Dis; 2010 Feb; 103(2):61-5. PubMed ID: 20226424
    [No Abstract]   [Full Text] [Related]  

  • 10. Heart matters: cardiovascular complications related to cancer treatment.
    Altena R; van Veldhuisen DJ
    Future Oncol; 2013 Feb; 9(2):137-40. PubMed ID: 23414462
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular disease in cancer survivors.
    Okwuosa TM; Anzevino S; Rao R
    Postgrad Med J; 2017 Feb; 93(1096):82-90. PubMed ID: 28123076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The support of genetic evidence for cardiovascular risk induced by antineoplastic drugs.
    Cui H; Zuo S; Liu Z; Liu H; Wang J; You T; Zheng Z; Zhou Y; Qian X; Yao H; Xie L; Liu T; Sham PC; Yu Y; Li MJ
    Sci Adv; 2020 Oct; 6(42):. PubMed ID: 33055159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1.
    Chang HM; Moudgil R; Scarabelli T; Okwuosa TM; Yeh ETH
    J Am Coll Cardiol; 2017 Nov; 70(20):2536-2551. PubMed ID: 29145954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drugs cardiotoxicity].
    Capilla E; Poyet R; Brocq FX; Pons F; Kerebel S; Jego C; Laurent P; Cellarier GR
    Presse Med; 2015 Oct; 44(10):995-1002. PubMed ID: 26153088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk management in community-dwelling elderly: opportunities for prevention.
    Ligthart SA; Richard E; van Gool WA; Moll van Charante EP
    Eur J Prev Cardiol; 2012 Dec; 19(6):1365-72. PubMed ID: 21930719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac disease in cancer patients: an overview.
    Mann DL; Krone RJ
    Prog Cardiovasc Dis; 2010; 53(2):80-7. PubMed ID: 20728694
    [No Abstract]   [Full Text] [Related]  

  • 17. From geriatric cardiology to 'cardio-geriatric' prevention and rehabilitation: Need for a new core curriculum?
    Pedretti RF; Ambrosetti M; Sarzi Braga S
    Eur J Prev Cardiol; 2020 Mar; 27(5):550-552. PubMed ID: 31537122
    [No Abstract]   [Full Text] [Related]  

  • 18. Challenges and controversies in the prevention and treatment of cardiovascular disease in very elderly patients.
    Kitzman DW
    Am J Geriatr Cardiol; 2003; 12(6):343. PubMed ID: 14610380
    [No Abstract]   [Full Text] [Related]  

  • 19. Statin adherence and risk of all-cause, cancer, and cardiovascular mortality among dyslipidemia patients: A time-dependent analysis.
    Lee YR; Oh SS; Jang SI; Park EC
    Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2207-2214. PubMed ID: 32912787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Risk Factors and Physical Activity for the Prevention of Cardiovascular Diseases in the Elderly.
    Ciumărnean L; Milaciu MV; Negrean V; Orășan OH; Vesa SC; Sălăgean O; Iluţ S; Vlaicu SI
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.